Literature DB >> 29238041

FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.

Jing-Bo Yang1, Zhi-Bin Zhao1,2, Qing-Zhi Liu1,2, Tai-Dou Hu1,2, Jie Long1,2, Kai Yan1,2, Zhe-Xiong Lian3,4,5.   

Abstract

Macrophages are a critical component in host immune responses against tumor. In this work we investigated the role of forkhead box O1 (FoxO1) in the transcriptional regulation in macrophages, which affects the anti-tumor functions of tumor-associated macrophages (TAMs). First, we showed that TAMs expressed reduced levels of FoxO1, which was associated with their protumoral M2 polarization state. The suppression of FoxO1 expression in TAM was induced by the hypoxic condition in the tumor microenviroment. Next, we confirmed that FoxO1 positively regulates MHC-II genes by binding to the promoter region of Ciita gene, the master activator of multiple MHC-II genes. Loss of FoxO1 in TAMs resulted in reduced MHC-II expression. Furthermore, we used FoxO1 conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth. These results demonstrate that the protumoral property of TAMs is induced by the hypoxia-triggered FoxO1 deficiency, which could be a potential target of novel anti-tumor therapies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29238041     DOI: 10.1038/s41388-017-0048-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

4.  Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis.

Authors:  Guosong Jiang; Amy D Wu; Chao Huang; Jiayan Gu; Liping Zhang; Haishan Huang; Xin Liao; Jingxia Li; Dongyun Zhang; Xingruo Zeng; Honglei Jin; Haojie Huang; Chuanshu Huang
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-14

5.  Distinct role of FoxO1 in M-CSF- and GM-CSF-differentiated macrophages contributes LPS-mediated IL-10: implication in hyperglycemia.

Authors:  Sangwoon Chung; Ravi Ranjan; Yong Gyu Lee; Gye Young Park; Manjula Karpurapu; Jing Deng; Lei Xiao; Ji Young Kim; Terry G Unterman; John W Christman
Journal:  J Leukoc Biol       Date:  2014-11-24       Impact factor: 4.962

6.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

Authors:  Charlotte Rolny; Massimiliano Mazzone; Sònia Tugues; Damya Laoui; Irja Johansson; Cathy Coulon; Mario Leonardo Squadrito; Inmaculada Segura; Xiujuan Li; Ellen Knevels; Sandra Costa; Stefan Vinckier; Tom Dresselaer; Peter Åkerud; Maria De Mol; Henriikka Salomäki; Mia Phillipson; Sabine Wyns; Erik Larsson; Ian Buysschaert; Johan Botling; Uwe Himmelreich; Jo A Van Ginderachter; Michele De Palma; Mieke Dewerchin; Lena Claesson-Welsh; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

Review 7.  Immature myeloid cells and cancer-associated immune suppression.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2002-04-24       Impact factor: 6.968

8.  Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice.

Authors:  Benfan Wang; Qinyan Li; Li Qin; Siting Zhao; Jinyan Wang; Xiaoping Chen
Journal:  BMC Immunol       Date:  2011-08-04       Impact factor: 3.615

9.  Defective generation and maturation of dendritic cells from monocytes in colorectal cancer patients during the course of disease.

Authors:  Giulia Orsini; Annalisa Legitimo; Alessandra Failli; Paola Ferrari; Andrea Nicolini; Roberto Spisni; Paolo Miccoli; Rita Consolini
Journal:  Int J Mol Sci       Date:  2013-11-07       Impact factor: 5.923

10.  JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles.

Authors:  Anthony Mathelier; Oriol Fornes; David J Arenillas; Chih-Yu Chen; Grégoire Denay; Jessica Lee; Wenqiang Shi; Casper Shyr; Ge Tan; Rebecca Worsley-Hunt; Allen W Zhang; François Parcy; Boris Lenhard; Albin Sandelin; Wyeth W Wasserman
Journal:  Nucleic Acids Res       Date:  2015-11-03       Impact factor: 16.971

View more
  14 in total

1.  The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.

Authors:  Lika Gamaev; Lina Mizrahi; Tomer Friehmann; Nofar Rosenberg; Orit Pappo; Devorah Olam; Evelyne Zeira; Keren Bahar Halpern; Stefano Caruso; Jessica Zucman-Rossi; Jonathan H Axelrod; Eithan Galun; Daniel S Goldenberg
Journal:  Oncogene       Date:  2020-10-22       Impact factor: 9.867

2.  Forkhead transcription factor FOXO3a mediates interferon-γ-induced MHC II transcription in macrophages.

Authors:  Xiaoyan Wu; Zhiwen Fan; Ming Chen; Yi Chen; Danyan Rong; Zhiwei Cui; Yibiao Yuan; Lili Zhuo; Yong Xu
Journal:  Immunology       Date:  2019-10-03       Impact factor: 7.397

Review 3.  Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?

Authors:  Xiaojun Zhang; Lusheng Jiang; Huimin Liu
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

4.  CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.

Authors:  Xinxing Wang; Wei Sheng; Tao Xu; Jiawen Xu; Ruyi Gao; Zhenhai Zhang
Journal:  Aging (Albany NY)       Date:  2021-04-23       Impact factor: 5.682

5.  The impact of DNA methylation on the cancer proteome.

Authors:  Majed Mohamed Magzoub; Marcos Prunello; Kevin Brennan; Olivier Gevaert
Journal:  PLoS Comput Biol       Date:  2019-07-29       Impact factor: 4.475

Review 6.  Mucosal Immunity and the FOXO1 Transcription Factors.

Authors:  Dana T Graves; Tatyana N Milovanova
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

Review 7.  Non-coding RNAs regulation of macrophage polarization in cancer.

Authors:  Swati Mohapatra; Carlotta Pioppini; Bulent Ozpolat; George A Calin
Journal:  Mol Cancer       Date:  2021-02-01       Impact factor: 27.401

Review 8.  Metabolic Regulation of Macrophage Activation.

Authors:  Ourania Kolliniati; Eleftheria Ieronymaki; Eleni Vergadi; Christos Tsatsanis
Journal:  J Innate Immun       Date:  2021-07-09       Impact factor: 7.349

Review 9.  COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.

Authors:  Patrick C Bradshaw; William A Seeds; Alexandra C Miller; Vikrant R Mahajan; William M Curtis
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

10.  Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming.

Authors:  Kai Yan; Tian-Tian Da; Zhen-Hua Bian; Yi He; Meng-Chu Liu; Qing-Zhi Liu; Jie Long; Liang Li; Cai-Yue Gao; Shu-Han Yang; Zhi-Bin Zhao; Zhe-Xiong Lian
Journal:  Cell Death Dis       Date:  2020-09-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.